NCT04506944

Brief Summary

There is enough evidence to suggest that scrub typhus and spotted fever group rickettsioses are common causes of febrile illness in India. Serological evidence also exists for murine typhus, but is rarely tested for. Incidence, risk factors, clinical features and molecular epidemiology of these three infections are poorly understood. Delays in disease recognition and treatment may cause thousands of preventable deaths across India. The objectives of the research are to determine the incidence and risk factors of scrub typhus, spotted fever and murine typhus by severity, to determine clinical features of these neglected and often unrecognized infections. Further to study the effect of previous infection on incidence and severity of subsequent infections. Finally to study the association between vector parameters and scrub typhus risk. Enrolled will be 30,000 individuals who will be followed up for the development of fever using active and passive surveillance. Active surveillance will include household screening every 3-6 weeks. Fever cases occuring in the past two months will be tested for Scrub typhus, murine typhus and spotted fever IgG/IgM. 4000 individuals will be followed up by annual serological testing to identify asymptomatic infections. Participants notifying the study team with ongoing fever will undergo blood testing for acute diagnosis of rickettsial infection (IgM, PCR). In addition, we will enroll fever cases at study clinics who are not part of the main cohort. The research includes spatial and socio-economic risk factor analysis. Rodents carrying mite larvae will be trapped to compare the intensity of mite infestation between areas of high and low risk for human scrub typhus. The data on incidence, burden of disease and environmental determinants of scrub typhus, spotted fever and murine typhus will be used for health care planning and information campaigns for the public and medical professionals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32,566

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2020

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

August 7, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 10, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 5, 2022

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

October 5, 2023

Status Verified

October 1, 2023

Enrollment Period

2 years

First QC Date

August 7, 2020

Last Update Submit

October 4, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Incidence of scrub typhus

    clinically apparent infection

    2 years

  • Incidence of spotted fever

    clinically apparent infection

    2 years

  • Incidence of murine typhus

    clinically apparent infection

    2 years

Secondary Outcomes (6)

  • Incidence of serological infection (scrub typhus)

    2 years

  • Incidence of serological infection (spotted fever)

    2 years

  • Incidence of serological infection (murine typhus)

    2 years

  • Incidence of complicated infection (scrub typhus)

    2 years

  • Incidence of complicated infection (spotted fever)

    2 years

  • +1 more secondary outcomes

Study Arms (3)

General population

Whole population of scrub typhus endemic villages

Other: No intervention

hospital case population

cases recruited at study clinics who are not enrolled in general population cohort

Other: No intervention

Serological cohort

random subset of 4000 participants above the age of 10 drawn from general population cohort

Other: No intervention

Interventions

No specific exposure is explored.

General populationSerological cohorthospital case population

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

General population cohort: all residents in scrub typhus endemic villages Serological cohort: random sample of 4000 individuals older than 10 years present at the time of the initial baseline survey visit hospital case cohort: cases of all ages attending study clinics for undifferentiated fever of at least 5 days duration

You may qualify if:

  • General population cohort: residing in study villages
  • serological cohort: aged 10 years or older
  • Hospital cohort: all ages

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Christian Medical College

Vellore, Tamil Nadu, 632004, India

Location

Related Publications (1)

  • Devamani C, Alexander N, Chandramohan D, Stenos J, Cameron M, Abhilash KPP, Mangtani P, Blacksell S, Vu HTT, Rose W, Schmidt WP. Incidence of Scrub Typhus in Rural South India. N Engl J Med. 2025 Mar 13;392(11):1089-1099. doi: 10.1056/NEJMoa2408645.

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples from human participants: serum for serological testing, buffy coat for rickettsia PCR Eschar and skin biopsies for rickettsia PCR Arthropod vector samples: PCR for rickettsia Rodent tissue samples: PCR for rickettsia

MeSH Terms

Conditions

Scrub TyphusSpotted Fever Group RickettsiosisTyphus, Endemic Flea-Borne

Condition Hierarchy (Ancestors)

Rickettsiaceae InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsVector Borne DiseasesRickettsia InfectionsTick-Borne Diseases

Study Officials

  • Wolf-Peter Schmidt, PhD

    London School of Hygiene and Tropical Medicine

    PRINCIPAL INVESTIGATOR
  • Daniel Chandramohan, PhD

    London School of Hygiene and Tropical Medicine

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 7, 2020

First Posted

August 10, 2020

Study Start

August 1, 2020

Primary Completion

August 5, 2022

Study Completion

July 31, 2023

Last Updated

October 5, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will share

de-identified case data will be made available at LSHTMs data repository

Shared Documents
STUDY PROTOCOL, ICF, ANALYTIC CODE
Time Frame
from 12/2022 indefinitely
Access Criteria
on request
More information

Locations